We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
How to control lymphangiogenesis: A novel role for rapamycin.
- Authors
Kerjaschki, D.
- Abstract
Analysis of the lymphatic microvasculature has become possible only recently by the discovery of novel proteins specifically expressed in lymphatic endothelial cells only. Therapeutic manipulation of de novo lymphangiogenesis might become clinically relevant in the future in diverse situations, such as renal transplant rejection. In this issue Huber et al. demonstrate that rapamycin acts as an efficient inhibitor of lymphangiogenesis.Kidney International (2007) 71, 717–719. doi:10.1038/sj.ki.5002184
- Subjects
RAPAMYCIN; KIDNEY diseases; IMMUNOSUPPRESSIVE agents; CLINICAL trials; NEPHROLOGY
- Publication
Kidney International, 2007, Vol 71, Issue 8, p717
- ISSN
0085-2538
- Publication type
Article
- DOI
10.1038/sj.ki.5002184